DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 0.00 0.00%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

51.19 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DRI $51.19 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $51.19
Daily Range $0.00 - $0.00
52-Week Range $43.56 - $54.89
Market Cap $6.8B
P/E Ratio 55.64
Dividend (Yield) $2.20 (4.3%)
Ex-Dividend Date
Dividend Pay Date
10/08/14
11/03/14
Volume 0
Average Daily Volume 1,594,637
Current FY EPS $2.25

Sector

Services

Industry

Leisure Equipment and Products

Darden Restaurants, Inc. (DRI) Description

A publicly held casual dining restaurant company that operates Red Lobster, Olive Garden, Bahamas Breeze, and Seasons restaurants. The company owns and operates all of the restaurants in the United States and Canada. Website: http://www.darden.com/

News & Commentary Rss Feed

Here's How Olive Garden Should Have Responded To Activists

Olive Garden should've been more aggressive in its response to activism.

Don't Bet On A Quick Rebound For Bloomin' Brands

Investor to Olive Garden: Stop Serving So Many Breadsticks... and 3 More Fixes We Want to See!

If activist investor Starboard Value gets its way, your Olive Garden experience is about to change.

Jim Cramer's Top Stock Picks: RAD DRI DBD BAS

Jim Cramer's 'Mad Money' Recap: Stop Worrying About Alibaba's IPO

What To Hold: 3 Hold-Rated Dividend Stocks NTI, DRI, ATLS

Are Olive Garden's Investors Now Trying to Micromanage the Italian Restaurant?

Do the Italian restaurant's investors know just a little too much about the business?

UPDATE: Darden Issues Release Urging Holders to Vote for Its Board Nominees

Fast Money Picks For September 17 - Apple Inc., EOG Resources Inc And More

Darden (DRI) Responds to Starboard's Claims, Plan on Track - Analyst Blog

See More DRI News...

DRI's Top Competitors

DRI $51.19 (0.00%)
Current stock: DRI
MCD $94.36 (0.94%)
Current stock: MCD
CUK $40.45 (1.28%)
Current stock: CUK
CCL $40.72 (0.00%)
Current stock: CCL